Kumagai Katsuyoshi

クマガイカツヨシ | Kumagai Katsuyoshi

Affiliation and department：
Job title：助教
Research theme for competitive and other funds (10)：

2021 - 2024 RNA activationにおける分子機構の解析
2020 - 2024 子宮頸癌の新規予防法開発
2018 - 2021 新規RNA干渉核酸の探索および機能解析
2016 - 2019 Function of type 2 diabetes susceptibility genes SLC16A11/13
2015 - 2018 Development of novel form of mimic microRNA for microRNA replacement therapy.

Show all

Papers (28)：

Katsuyoshi Kumagai, Masakatsu Takanashi, Shin-ichiro Ohno, Yuichirou Harada, Koji Fujita, Keiki Oikawa, Katsuko Sudo, Shun-ichi Ikeda, Hirotaka Nishi, Kosuke Oikawa, et al. WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7. Oncogene. 2021
Koichiro Tsujimaru, Masakatsu Takanashi, Katsuko Sudo, Akio Ishikawa, Shoichiro Mineo, Shinobu Ueda, Katsuyoshi Kumagai, Masahiko Kuroda. Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice. Regenerative therapy. 2020. 15. 305-311
Katsuyoshi Kumagai, Masakatsu Takanashi, Shin-Ichiro Ohno, Masahiko Kuroda, Katsuko Sudo. An improved Red/ET recombineering system and mouse ES cells culture conditions for the generation of targeted mutant mice. Experimental animals. 2017. 66. 2. 125-136
Naoto Kubota, Tetsuya Kubota, Eiji Kajiwara, Tomokatsu Iwamura, Hiroki Kumagai, Taku Watanabe, Mariko Inoue, Iseki Takamoto, Takayoshi Sasako, Katsuyoshi Kumagai, et al. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nature communications. 2016. 7. 12977-12977
Shin-Ichiro Ohno, Karen Itano, Yuichirou Harada, Koutaro Asada, Keiki Oikawa, Mikie Kashiwazako, Hikaru Okuyama, Katsuyoshi Kumagai, Masakatsu Takanashi, Katsuko Sudo, et al. Development of novel small hairpin RNAs that do not require processing by dicer or AGO2. Molecular Therapy. 2016. 24. 7. 1278-1289

ｍore...

MISC (6)：

Tomohiko Sato, Susumu Goyama, Keisuke Kataoka, Ryo Nasu, Takako Tsuruta-Kishino, Yuki Kagoya, Arika Nukina, Katsuyoshi Kumagai, Naoto Kubota, Masahiro Nakagawa, et al. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. CANCER RESEARCH. 2014. 74. 19
Iseki Takamoto, Naoto Kubota, Katsuyoshi Kumagai, Atsushi Obata, Tetsuya Kubota, Kohjiro Ueki, Takashi Kadowaki. Role of Tcf7l2-Mediated Pathway in Pancreatic Beta Cell In Vivo. DIABETES. 2012. 61. A30-A30
Tomohiko Sato, Susumu Goyama, Keisuke Kataoka, Takako Tsuruta, Masahiro Nakagawa, Keiki Kumano, Katsuyoshi Kumagai, Naoto Kubota, Takashi Kadowaki, Mineo Kurokawa. Regulation of Chronic Myelogenous Leukemia Stem Cells by Leukemia Oncogene Evi1. BLOOD. 2011. 118. 21. 440-441
高本偉碩, 窪田直人, 小畑淳史, 熊谷勝義, 窪田哲也, 北村忠弘, 植木浩二郎, 門脇孝. 膵β細胞のTcf7l2は膵β細胞量維持に重要な役割を果たしている. 日本体質医学会雑誌. 2011. 73. 3
Keisuke Kataoka, Tomohiko Sato, Akihide Yoshimi, Susumu Goyama, Takako Tsuruta, Shunya Arai, Yoichi Imai, Katsuyoshi Kumagai, Naoto Kubota, Takashi Kadowaki, et al. Evil Is a Stem Cell-Specific Regulator of Self-Renewal Capacity In the Definitive Hematopoietic System. BLOOD. 2010. 116. 21. 365-365

ｍore...

Professional career (1)：

博士(農学) (東京大学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page